Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation
Celia C. Cubitt, … , Jacqueline E. Payton, Todd A. Fehniger
Celia C. Cubitt, … , Jacqueline E. Payton, Todd A. Fehniger
Published May 28, 2024
Citation Information: J Clin Invest. 2024;134(15):e173602. https://doi.org/10.1172/JCI173602.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 16

Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activation

  • Text
  • PDF
Abstract

The surface receptor CD8α is present on 20%–80% of human (but not mouse) NK cells, yet its function on NK cells remains poorly understood. CD8α expression on donor NK cells was associated with a lack of therapeutic responses in patients with leukemia in prior studies, thus, we hypothesized that CD8α may affect critical NK cell functions. Here, we discovered that CD8α– NK cells had improved control of leukemia in xenograft models compared with CD8α+ NK cells, likely due to an enhanced capacity for proliferation. Unexpectedly, we found that CD8α expression was induced on approximately 30% of previously CD8α– NK cells following IL-15 stimulation. These induced CD8α+ (iCD8α+) NK cells had the greatest proliferation, responses to IL-15 signaling, and metabolic activity compared with those that sustained existing CD8α expression (sustained CD8α+) or those that remained CD8α– (persistent CD8α–). These iCD8α+ cells originated from an IL-15Rβhi NK cell population, with CD8α expression dependent on the transcription factor RUNX3. Moreover, CD8A CRISPR/Cas9 deletion resulted in enhanced responses through the activating receptor NKp30, possibly by modulating KIR inhibitory function. Thus, CD8α status identified human NK cell capacity for IL-15–induced proliferation and metabolism in a time-dependent fashion, and its presence had a suppressive effect on NK cell–activating receptors.

Authors

Celia C. Cubitt, Pamela Wong, Hannah K. Dorando, Jennifer A. Foltz, Jennifer Tran, Lynne Marsala, Nancy D. Marin, Mark Foster, Timothy Schappe, Hijab Fatima, Michelle Becker-Hapak, Alice Y. Zhou, Kimberly Hwang, Miriam T. Jacobs, David A. Russler-Germain, Emily M. Mace, Melissa M. Berrien-Elliott, Jacqueline E. Payton, Todd A. Fehniger

×

Figure 5

RUNX3 regulates CD8α expression.

Options: View larger image (or click on image) Download as PowerPoint
RUNX3 regulates CD8α expression.
(A) MFI of RUNX3 on day 6 within the in...
(A) MFI of RUNX3 on day 6 within the indicated cell populations cultured in 1 ng/mL IL-15. n = 5 donors and 3 independent experiments. (B–D) NK cells were electroporated with RUNX3 sgRNA and Cas9 mRNA, cultured in vitro for 48 hours, and then sorted on the basis of CD8α expression. NSG mice were injected i.v. with sorted CD8α+/– control or RUNX3-KO cells and supported with i.p. rhIL-15 for 9 days. (B) Experimental schema. (C and D) Percentage of human NK cells in the liver expressing CD8α within RUNX3+ or RUNX3– cell populations that were originally sorted as (C) CD8α+ or (D) CD8α–. n = 3 donors and 2 independent experiments. Data represent the mean ± SEM. **P < 0.01, by (A) repeated-measures 1-way ANOVA and (C and D) ratio-paired, 2-tailed Student’s t test. (E and F) NK cells were electroporated with control or RUNX3 gRNA and Cas9 mRNA, cultured in 5 ng/mL IL-15 for 9 days, and assessed for H3K27ac abundance using CUT&TAG. (E) Integrative Genomics Viewer (IGV) tracks showing H3K27ac peaks within the CD8A locus for control (ctrl) and RUNX3-KO donor pairs, with the log2 FC for each donor pair for the entire CD8A locus shown. (F) Volcano plot showing the average log2 FC and –log10 P value, determined by matched, paired, 2-tailed Student’s t test, for donor-matched RUNX3-KO versus control H3K27ac signal for gene loci. Genes in highlighted in red had significantly increased H3K27ac signal, and genes in blue had significantly decreased H3K27ac signal in RUNX3-KO cells with log2 FC cutoffs of absolute (0.5) or higher for at least 3 of 4 donors. We filtered genes with P < 0.05 using the results of 1-sided Student’s t tests (peaks lost/lower in KO or peaks gained/higher in KO), a log2 fold change ≤ -0.5 or ≥ 0.5, respectively) in at least 3 of 4 donors, for genes expressed in NK cells. n = 4 donors and 2 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 28 X users
On 1 Facebook pages
19 readers on Mendeley
See more details